Elon Musk’s brain-implant company Neuralink has chosen the Barrow Neurological Institute in Phoenix, Arizona, as the initial study site to test its Telepathy device. The first participant in ...
Synchron Inc, a rival to Elon Musk’s Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval for its device, the ...
Elon Musk's neurotechnology company, Neuralink, has selected Phoenix-based Barrow Neurological Institute as the inaugural site for conducting its Neuralink PRIME Study. The first human who ...
WASHINGTON, April 8 (Reuters) - Synchron Inc, a rival to Elon Musk's Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial ...
Sen. Tommy Tuberville, R-Ala., appeared astonished over South Carolina coach Dawn Staley’s comments about transgender athletes in women’s sports over the weekend. Tuberville, who has pushed to ...
Robert F. Kennedy Jr. said Friday he is still “listening” to arguments about the riots at the U.S. Capitol on Jan. 6, 2021, to try to “hear every side.” Taylor James Johnatakis, a ...
Despite facing challenges such as lagging returns and political scrutiny, sustainable funds experienced continued growth on the back of market appreciation, with assets reaching $323 billion by ...
Fort Huachuca develops and tests command, control, communications, computers, combat systems, intelligence, surveillance and reconnaissance capabilities; delivers intelligence and unmanned ...
The U.S. Olympic team roster for the 2024 Paris Games will ultimately include more than 500 athletes. It will be one of, if not the biggest, delegation at the Games, which open July 26. Athletes will ...
Mutual fund investors have saved billions in fund fees over the past two decades. In 2022, the average expense ratio of all U.S. open-end mutual funds and exchange-traded funds was 0.37%, compared ...
WASHINGTON (Reuters) - Synchron Inc, a rival to Elon Musk's Neuralink brain implant startup, is preparing to recruit patients for a large-scale clinical trial required to seek commercial approval ...